Cited by 40Antifungal resistance and susceptibilityFungal and yeast genetics researchFungal Plant Pathogen Control

The Candida glabrata Upc2A transcription factor is a global regulator of antifungal drug resistance pathways

Open access
Vu, Bao Gia, Stamnes, Mark A., Li, Yu, Rogers, P. David, Moye-Rowley, W. Scott·2021·PLOS Genetics

Abstract

The most commonly used antifungal drugs are the azole compounds, which interfere with biosynthesis of the fungal-specific sterol: ergosterol. The pathogenic yeast Candida glabrata commonly acquires resistance to azole drugs like fluconazole via mutations in a gene encoding a transcription factor called PDR1 . These PDR1 mutations lead to overproduction of drug transporter proteins like the ATP-binding cassette transporter Cdr1. In other Candida species, mutant forms of a transcription factor called Upc2 are associated with azole resistance, owing to the important role of this protein in control of expression of genes encoding enzymes involved in the ergosterol biosynthetic pathway. Recently, the C . glabrata Upc2A factor was demonstrated to be required for normal azole resistance, even in the presence of a hyperactive mutant form of PDR1 . Using genome-scale approaches, we define the network of genes bound and regulated by Upc2A. By analogy to a previously described hyperactive UPC2 mutation found in Saccharomyces cerevisiae , we generated a similar form of Upc2A in C . glabrata called G898D Upc2A. Analysis of Upc2A genomic binding sites demonstrated that wild-type Upc2A binding to target genes was strongly induced by fluconazole while G898D Upc2A bound similarly, irrespective of drug treatment. Transcriptomic analyses revealed that, in addition to the well-described ERG genes, a large group of genes encoding components of the translational apparatus along with membrane proteins were responsive to Upc2A. These Upc2A-regulated membrane protein-encoding genes are often targets of the Pdr1 transcription factor, demonstrating the high degree of overlap between these two regulatory networks. Finally, we provide evidence that Upc2A impacts the Pdr1-Cdr1 system and also modulates resistance to caspofungin. These studies provide a new perspective of Upc2A as a master regulator of lipid and membrane protein biosynthesis.

AI snapshot

Written from the paper’s full text.

TL;DR

Upc2A in *Candida glabrata* is a global transcriptional regulator that binds over 1,000 promoters under fluconazole stress and overlaps extensively with the Pdr1 regulon. A constructed G898D gain-of-function Upc2A confers elevated fluconazole resistance and constitutively binds targets, while loss of Upc2A reduces FKS1 expression and increases caspofungin sensitivity.

Key findings

  • ChIP-seq identified >1,000 Upc2A-bound promoters in wild-type cells treated with fluconazole; 565 promoters were bound only under fluconazole, 309 were bound under all four conditions, and 85 were bound only under induced conditions.
  • More than 50% of Pdr1 target promoters were also bound by Upc2A, and Upc2A binding sites were required for normal fluconazole induction of *CDR1* and *PDR1*; loss of the *CDR1* SRE caused the largest reduction in fluconazole resistance.
  • RNA-seq showed that only 53 fluconazole-induced genes required Upc2A binding for induction, while 542 fluconazole-induced genes were not dependent on Upc2A; 64 genes required Upc2A but were not bound by it, including *ERG4*, *ERG8*, *ERG9*, *ERG24*, *ERG26*, and *ERG27*.
  • The G898D Upc2A allele elevated fluconazole resistance and increased only 11 genes at least 1.4-fold, 9 of which were ergosterol biosynthesis genes; loss of *UPC2A* reduced basal *FKS1* expression by 50% and *FKS2* by 30%, and caused hypersensitivity to caspofungin, caffeine, and high pH.

Methods

  • Isogenic *C. glabrata* strains varying in *UPC2A* allele, including wild-type, *upc2AΔ*, 3X HA-tagged wild-type, and 3X HA-G898D *UPC2A*, were grown with or without fluconazole and assayed by serial dilution, RT-qPCR, western blotting, and β-galactosidase reporter assays.
  • ChIP-seq with anti-HA was performed on wild-type and G898D Upc2A with or without fluconazole; peaks were called with MACS2, differential binding with BDGdiff, and motifs with MEME-ChIP. RNA-seq compared wild-type and *upc2AΔ* cells with or without fluconazole, and wild-type versus G898D *UPC2A* without fluconazole.
  • DNA binding was validated by DNase I protection and EMSA using recombinant Upc2A DNA-binding domain and wild-type or mutant SRE probes from *ERG1*, *CDR1*, *PDR1*, and *FKS1* promoters.

Limitations

  • The paper states that a large group of Upc2A-bound genes, including translational machinery components, “await experimental analysis to test their functionality,” and that the molecular basis of G898D Upc2A transcriptional effects is “still only partially understood.”
  • The paper notes that further dissection of the Upc2A regulon is required to illuminate modes of control for genes regulated in the presence or absence of Upc2A, and that experiments testing G898D Upc2A under fluconazole are underway.
  • Evident from the text: the G898D allele was engineered by analogy to *S. cerevisiae* and is not a naturally occurring *C. glabrata* allele; many conclusions rely on laboratory strain backgrounds and in vitro binding assays rather than clinical isolates.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1371/journal.pgen.1009582

Cites

50 of 50 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Claims the paper makes

0 of 39 cited sources checked · 0 supported · 0 flagged

  • Findingown data

    The G898D mutant form of Upc2A confers elevated fluconazole resistance in C. glabrata.

    “This mutant Upc2A drove elevated fluconazole resistance and behaved like the hyperactive S. cerevisiae factor.”
    • Also stated in: § A gain-of-function form of Upc2A confers elevated fluconazole resistance · plain
      “Introduction of the G898D mutation into UPC2A led to the resulting factor exhibiting elevated fluconazole resistance when compared to either the tagged or untagged version of the wild-type gene.”
    Quote in the paperSubstantial claim
  • Findingown data

    Loss of UPC2A causes a dramatic increase in fluconazole susceptibility.

    “Loss of UPC2A caused a dramatic increase in fluconazole susceptibility.”
    Quote in the paperSubstantial claim
  • Findingown data

    ERG11 is an example of a locus controlled by Upc2A but not Pdr1.

    “The ERG11 gene is an example of a locus controlled by Upc2A but not Pdr1.”
    Quote in the paperNot a substantial claim
  • Findingown data

    The large group of Upc2A-bound genes includes loci not typically considered as target genes, such as components of the translational machinery.

    “This large group of Upc2A-bound genes include loci not typically considered as target genes, such as components of the translational machinery”
    Quote in the paperNot a substantial claim
  • Findingown data

    The third largest class of promoters (85) were only bound by Upc2A under induced conditions (wild-type + fluconazole and G898D Upc2A +/- fluconazole).

    “The third largest class of promoters (85) were only bound by Upc2A under conditions we consider induced (wild-type + fluconazole and G898D Upc2A +/- fluconazole).”
    Quote in the paperNot a substantial claim
  • May combine two claims. 42
  • The quote only partly states this claim. 1
  • Classified as probably not a substantial claim. 23
  • May combine two claims.

    Findingown data

    The presence of the G898D UPC2A gene leads to strong elevation of ERG11 transcription in the absence of fluconazole but has no significant effect on other tested genes.

    “The presence of the G898D UPC2A gene led to a strong elevation of ERG11 transcription in the absence of fluconazole but had no significant effect on the other genes (Fig 1B).”
    Quote in the paperSubstantial claim
  • May combine two claims. The quote only partly states this claim.

    Findingown data

    The G898D UPC2A allele supports normal fluconazole induction of Cdr1 and shows a modest reduction (~80% of wild-type) in Pdr1 activation.

    “The presence of the G899D UPC2A allele supported normal fluconazole induction of Cdr1 and showed a modest reduction (~80% of wild-type) in Pdr1 activation.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    All these genes are Upc2A target loci but exhibit unique patterns of association with this factor.

    “While all these genes are Upc2A target loci, they exhibited unique patterns of association with this factor.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    ChIP-seq data indicated Upc2A bound to roughly 1000 genes and that this binding was highly induced by fluconazole.

    “ChIP-seq data indicated Upc2A bound to roughly 1000 genes and that this binding was highly induced by fluconazole.”
    • Also stated in: § Global analysis of Upc2A direct transcriptional targets · plain
      “The largest number of bound genes was seen for the wild-type factor in the presence of fluconazole (>1000 promoters bound).”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    The central CGTA sequence is conserved between C. glabrata and S. cerevisiae, although the C. glabrata element has a nearby conserved element (CACAGA) with relatively constant spacing.

    “The central CGTA sequence is conserved between C. glabrata and S. cerevisiae, although the C. glabrata element has a nearby conserved element (CACAGA) that shows a relatively constant spacing.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Findingown data

    Fluconazole treatment elevates transcription of all Upc2A target genes, but elevated ERG11 mRNA levels seen in the absence of drug are not further induced by fluconazole when G898D Upc2A is present.

    “Treatment with fluconazole elevated transcription of all Upc2A target genes although the elevated ERG11 mRNA levels seen in the absence of drug were not further induced by fluconazole when G898D Upc2A was present.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    The majority of fluconazole-induced genes (542) were not dependent on the presence of Upc2A, while 64 genes were fluconazole-induced, required Upc2A but were not bound by this factor.

    “The majority of fluconazole-induced genes (542) were not dependent on the presence of Upc2A while 64 genes were fluconazole-induced, required the presence of Upc2A but were not bound by this factor.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    Loss of UPC2A caused hypersensitivity to caspofungin, caffeine and high pH.

    “Loss of UPC2A caused hypersensitivity to all these agents (Fig 6A) while both epitope-tagged alleles behaved like the wild-type strain.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    Only the group of 201 genes showed any significant GO term enrichment, with response to stress and glycogen catabolism being the top two categories.

    “Only the group of 201 genes showed any significant GO term enrichment with specific groups of genes involved in the response to stress and glycogen catabolism being the top two categories.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Findingown data

    The PDR1 SRE showed a clear protected region but no associated hypersensitive site.

    “The CDR1 SRE exhibited two DNase I hypersensitive sites linked to Upc2A binding while the PDR1 SRE showed a clear protected region but no associated hypersensitive site.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Findingown data

    CDR1 and PDR1 probes both formed primarily a single size of complex that was greatly diminished when the mutant SRE probe was used.

    “CDR1 and PDR1 probes both formed primarily a single size of complex that was greatly diminished when the mutant SRE probe was used.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    Loss of the SRE from the CDR1 promoter caused a significant drop in expression when cells were treated with fluconazole, and this drop was enhanced when combined with the mSRE version of the PDR1 gene.

    “Loss of the SRE from the CDR1 promoter caused a significant drop in expression when cells were treated with fluconazole that was enhanced when combined with the mSRE version of the PDR1 gene.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    Only 53 genes required the presence of Upc2A DNA-binding activity to be induced by fluconazole, while 274 were induced either in the presence or absence of UPC2A, although all these genes were bound by Upc2A.

    “Strikingly, only 53 genes required the presence of Upc2A DNA-binding activity to be induced by fluconazole while 274 were induced either in the presence or the absence of the UPC2A gene, although all these genes were bound by Upc2A.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    CDR1 is a Upc2A target gene that is also regulated by Pdr1.

    “CDR1 represents a Upc2A target gene that is also regulated by Pdr1.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    Similar reductions in Cdr1 levels were seen in the absence of fluconazole, with removal of the SRE from both CDR1 and PDR1 causing the largest reduction.

    “Similar reductions in Cdr1 levels were seen in the absence of fluconazole, again with removal of the SRE from both CDR1 and PDR1 causing the largest reduction in Cdr1 levels.”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Findingown data

    The ERG1 promoter exhibited some of the strongest binding detected by ChIP-seq.

    “We selected ERG1 for analysis as the promoter for this gene exhibited some of the strongest binding detected by ChIP-seq”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Findingown data

    The other two categories of fluconazole-regulated Upc2A-bound genes were either induced in both wild-type and upc2AΔ cells (201 genes) or only in the absence of UPC2A (73 genes).

    “The other two categories of fluconazole-regulated Upc2A-bound genes were either induced in both wild-type and upc2AΔ cells (201 genes) or only in the absence of UPC2A (73 genes).”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    These 53 genes are both bound by Upc2A and respond to regulation via this factor.

    “These genes are both bound by Upc2A and respond to regulation via this factor.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    The ERG1 promoter showed the largest protected region of DNA and a strong DNase I hypersensitive site located immediately upstream of the SRE.

    “The ERG1 promoter, which contains an everted pair of SREs (Fig 4A), showed the largest protected region of DNA and a strong DNase I hypersensitive site located immediately upstream of the SRE (Fig 4B).”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Findingcitation

    Pdr1 DNA-binding is strongly upregulated in ρ0 cells, likely due in part to the large increase in PDR1 expression in this background compared to wild-type cells.

    “Pdr1 DNA-binding was strongly upregulated in ρ0 cells, likely due in part to the large increase in PDR1 expression in this background compared to wild-type cells [31].”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [31] S Paul, 2014, Identification of Genomic Binding Sites for Candida glabrata Pdr1 Transcription Factor in Wild-Type and rho0 Cells, Antimicrob Agents Chemother source

      Not checked in the free run.

  • May combine two claims.

    Findingown data

    The G898D Upc2A mutant protein shows a constitutively high number of ChIP-seq peaks that is not significantly altered by azole challenge.

    “Second, the G898D Upc2A mutant protein shows constitutively high number of ChIP-seq peaks that is not significantly altered by azole challenge.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    The wild-type FKS1 probe was strongly reduced in mobility when incubated with Upc2A, while the mSRE-containing probe exhibited a band of reduced intensity upon loss of this sequence element.

    “The wild-type FKS1 probe was strongly reduced in mobility when incubated with Upc2A while the mSRE-containing probe exhibited a band of reduced intensity upon loss of this sequence element.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    Only ~50 genes were both bound by Upc2A and dependent on Upc2A for fluconazole induction while 880 were induced in the presence of fluconazole independent of Upc2A.

    “However, only ~50 genes were both bound by Upc2A and dependent on Upc2A for fluconazole induction while 880 were induced in the presence of fluconazole independent of Upc2A (Fig 3A).”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

    Premisecitation

    GOF PDR1 alleles exhibit high levels of target gene expression and drive robust fluconazole resistance primarily through induction of expression of the ATP-binding cassette transporter-encoding gene CDR1.

    “The GOF PDR1 alleles exhibit high levels of target gene expression and drive robust fluconazole resistance primarily through induction of expression of the ATP-binding cassette transporter-encoding gene CDR1 [10,11].”
    Quote in the paperNot a substantial claim0 of 2 sources checked
    • cites [10] D Sanglard, 1999, The ATP binding cassette transporter gene CgCDR1 from Candida glabrata is involved in the resistance of clinical isolates to azole antifungal agents, Antimicrob Agents Chemother source

      Not checked in the free run.

    • cites [11] S Paul, 2014, Multidrug resistance in fungi: regulation of transporter-encoding gene expression, Frontiers in physiology source

      Not checked in the free run.

  • May combine two claims.

    Interpretationown data

    Upc2A impacts the Pdr1-Cdr1 system and modulates resistance to caspofungin.

    “Finally, we provide evidence that Upc2A impacts the Pdr1-Cdr1 system and also modulates resistance to caspofungin.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Premisecitation

    Fluconazole and ρ0 cells both involve a signal that activates the wild-type versions of Upc2A and/or Pdr1.

    “We selected these two conditions for comparison since both involve a signal that activates the wild-type versions of Upc2A and/or Pdr1 (fluconazole or ρ0 cells, respectively) [8,32].”
    Quote in the paperSubstantial claim0 of 2 sources checked
    • cites [8] HF Tsai, 2006, Candida glabrata PDR1, a transcriptional regulator of a pleiotropic drug resistance network, mediates azole resistance in clinical isolates and petite mutants, Antimicrob Agents Chemother source

      Not checked in the free run.

    • cites [32] S Paul, 2011, Regulation of the CgPdr1 transcription factor from the pathogen Candida glabrata, Eukaryot Cell source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing), S4 (based).

    Interpretationnone given

    Upc2A serves as a key coordinator of the biosynthesis of lipids and proteins destined to function in the membrane environment.

    “Upc2A appears to serve as a key coordinator of the biosynthesis of lipids and proteins that are destined to function in this membrane environment.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

    Interpretationcitation

    Upc2A appears to accumulate inside the nucleus upon ergosterol limitation where it binds to SRE-containing promoters.

    “These data agree with the model proposed earlier for ScUpc2 that Upc2A appeared to accumulate inside the nucleus upon ergosterol limitation where the factor then binds to SRE-containing promoters [22].”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [22] H Yang, 2015, Structural mechanism of ergosterol regulation by fungal sterol transcription factor Upc2, Nat Commun source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation

    In C. albicans, CaUpc2 is the primary transcriptional activator of CaERG11 and other ergosterol biosynthetic pathway genes.

    “CaUpc2, the primary transcriptional activator of CaERG11 and other ergosterol biosynthetic pathway genes [16].”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [16] SA Flowers, 2012, Gain-of-function mutations in UPC2 are a frequent cause of ERG11 upregulation in azole-resistant clinical isolates of Candida albicans, Eukaryot Cell source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation

    Fluconazole resistance is most commonly caused in C. glabrata by substitution mutations within the PDR1 gene.

    “Fluconazole resistance is most commonly caused in C. glabrata by substitution mutations within the PDR1 gene (See [6,21] for a review).”
    Quote in the paperNot a substantial claim0 of 2 sources checked
    • cites [6] MC Arendrup, 2017, Multidrug-Resistant Candida: Epidemiology, Molecular Mechanisms, and Treatment, J Infect Dis source

      Not checked in the free run.

    • cites [21] KR Healey, 2018, Fungal Resistance to Echinocandins and the MDR Phenomenon in Candida glabrata, J Fungi (Basel).

      Not checked in the free run.

  • May combine two claims.

    Premisecitation

    Upc2A is an activator of expression of both CDR1 and PDR1.

    “Our previous experiments have identified Upc2A as an activator of expression of both the ATP-binding cassette transporter-encoding gene CDR1 and the PDR1 gene encoding a key transcriptional activator of CDR1 [26].”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites [26] BG Vu, 2018, Construction and Use of a Recyclable Marker To Examine the Role of Major Facilitator Superfamily Protein Members in Candida glabrata Drug Resistance Phenotypes, mSphere

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

    Premisecitation

    ERG8 is in the earlier part of the ergosterol biosynthetic pathway while all other enzymes participate in the conversion of farnesyl pyrophosphate to ergosterol.

    “ERG8 is in the earlier part of the ergosterol biosynthetic pathway while all other enzymes participate in the conversion of farnesyl pyrophosphate to ergosterol (recently reviewed in [33]).”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [33] T Jorda, 2020, Regulation of Ergosterol Biosynthesis in Saccharomyces cerevisiae, Genes (Basel) source

      Not checked in the free run.

  • May combine two claims.

    Interpretationown data

    The complex responses to fluconazole treatment in C. glabrata are evidence for a multifactorial transcriptional network regulating ERG gene expression in which Upc2A participates as both a direct regulator of later pathway genes and an indirect regulator of early pathway genes.

    “We interpret these complex responses to fluconazole treatment in C. glabrata as evidence for a multifactorial transcriptional network regulating ERG gene expression in which Upc2A participates as both a direct (later pathway genes) and indirect (early pathway genes) regulator.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Interpretationown data

    Upc2A impacts a wide range of cellular processes as well as its well-described control of expression of genes involved in the ergosterol biosynthetic pathway.

    “Together, these data strongly suggest that Upc2A impacts a wide range of cellular process as well as its well-described control of expression of genes involved in the ergosterol biosynthetic pathway.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Interpretationreasoning

    The DNA-binding activity of wild-type but not G898D Upc2A is increased by fluconazole, possibly by an increase in nuclear localization.

    “these data support the view that the DNA-binding activity of wild-type but not G898D Upc2A is increased by the presence of fluconazole, possibly by an increase in nuclear localization [22].”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites [22] H Yang, 2015, Structural mechanism of ergosterol regulation by fungal sterol transcription factor Upc2, Nat Commun source

      Not checked in the free run.

  • May combine two claims.

    Premisecitation

    Caffeine and high pH are cell wall stresses and reflect general cell wall dysfunction.

    “Caffeine and high pH are cell wall stresses and reflect general cell wall dysfunction [34].”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites [34] BB Fuchs, 2009, Our paths might cross: the role of the fungal cell wall integrity pathway in stress response and cross talk with other stress response pathways, Eukaryot Cell source

      Not checked in the free run.

  • May combine two claims.

    Interpretationown data

    The SREs present in CDR1 and PDR1 are required for normal expression of these genes and for full fluconazole resistance.

    “Together, these data demonstrate that the SREs present in CDR1 and PDR1 are required for normal expression of these genes and for full fluconazole resistance.”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductnone given

    ChIP-seq read quality was confirmed using FastQC.

    “Read quality was confirmed using FastQC (Babraham Bioinformatics).”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Interpretationown data

    Loss of Upc2A has clear phenotypes but is certainly not the only regulator of ERG gene expression and fluconazole induction in C. glabrata.

    “Additionally, loss of Upc2A has clear phenotypes but is certainly not the only regulator of ERG gene expression and fluconazole induction in C. glabrata.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Interpretationreasoning

    Upc2A provides overarching control of the Pdr1 regulon and also a variety of other genes not under Pdr1 control, linking these classes through common transcriptional regulation.

    “We suggest Upc2A provides overarching control of both the Pdr1 regulon but also a variety of other genes that are not under Pdr1 control, serving to link these different classes of genes through this common transcriptional regulation.”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

    Study design and conductnone given

    RNA quantity and purity were determined by spectrophotometer and verified using a Bioanalyzer 2100.

    “The quantity and purity of RNA were determined by spectrophotometer (NanoDrop Technologies, Inc., Wilmington, DE) and verified using a Bioanalyzer 2100 (Agilent Technologies, Santa Clara, CA).”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Interpretationown data

    Upc2A-mediated gene activation is required for normal expression of FKS1 and wild-type caspofungin resistance.

    “These data provide evidence that Upc2A-mediated gene activation is required for normal expression of FKS1 and wild-type caspofungin resistance.”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation

    A ChIP-chip experiment found that C. albicans Upc2 associates with the CDR1 gene.

    “A ChIP-chip experiment was carried out on C. albicans Upc2 and this factor was found to associate with the CDR1 gene in this species [39].”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [39] S Znaidi, 2008, Genomewide location analysis of Candida albicans Upc2p, a regulator of sterol metabolism and azole drug resistance, Eukaryot Cell source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductown data

    The clones used for Upc2A DNA binding domain expression were sequence-verified.

    “Correct clones were sequenced verified and transformed into the BL21 DE3 E. coli expression strain (Thermo Fisher, Waltham, MA).”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S2 (checkable).

    Interpretationown data

    These data provide important new appreciation for the expansive role of Upc2A in control of gene expression.

    “These data provide important new appreciation for the expansive role of Upc2A in control of gene expression.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation

    The majority of C. albicans UPC2 GOF alleles cluster in a region of the protein between residues 642 and 648.

    “An interesting feature of the majority of C. albicans UPC2 GOF alleles is these all cluster with a region of the protein between residues 642 and 648 [16].”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [16] SA Flowers, 2012, Gain-of-function mutations in UPC2 are a frequent cause of ERG11 upregulation in azole-resistant clinical isolates of Candida albicans, Eukaryot Cell source

      Not checked in the free run.

  • May combine two claims.

    Interpretationown data

    ERG gene regulation is an important task for Upc2A but this factor clearly impacts transcription of a broad range of genes affecting multiple aspects of the plasma membrane.

    “ERG gene regulation is an important task for Upc2A but this factor clearly impacts transcription of a broad range of genes affecting multiple aspects of the plasma membrane.”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductnone given

    RT-qPCR data reported are from two biological replicates with two technical replicates of each.

    “Data reported are from two biological replicates with two technical replicates of each.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Interpretationown data

    These data are consistent with a model in which Upc2A nuclear accumulation is enhanced upon ergosterol limitation and this regulation requires the function of the region containing G898 in the C-terminus of this factor.

    “These data are consistent with a model in which Upc2A nuclear accumulation is enhanced upon ergosterol limitation and this regulation requires the function of the region containing G898 in the C-terminus of this factor.”
    Quote in the paperSubstantial claim
    • Rests on an assumption: Fluconazole treatment causes ergosterol limitation in C. glabrata.
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation

    The S. cerevisiae UPC2-1 allele, from which G898D UPC2A was derived, was originally isolated on the basis of permitting aerobic sterol uptake.

    “The S. cerevisiae UPC2-1 allele, from which we derived the G898D UPC2A, was originally isolated on the basis of permitting aerobic sterol uptake [19].”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [19] JH Crowley, 1998, A mutation in a purported regulatory gene affects control of sterol uptake in Saccharomyces cerevisiae, J Bacteriol source

      Not checked in the free run.

  • May combine two claims.

    Interpretationreasoning

    The connection between Upc2A and Pdr1 in C. glabrata may be a unique feature of this yeast and could help explain its high level of intrinsic azole resistance.

    “This suggests the possibility that this C. glabrata connection between Upc2A and Pdr1 is a unique feature of this yeast and could help explain the high level of intrinsic azole resistance seen in this organism.”
    Quote in the paperSubstantial claim
    • Rests on an assumption: C. glabrata has a high level of intrinsic azole resistance.
    • Rests on an assumption: There has been no follow-up linking C. albicans Upc2 with the Tac1 transcription factor or S. cerevisiae Upc2 with either ScPDR1 or ScPDR3.
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Interpretationreasoning

    The conserved location of these hypermorphic alleles suggests the possibility that a common function is being disrupted in both organisms.

    “The conserved location of these hypermorphic alleles suggests the possibility that a common function is being disrupted in both organisms.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductown data

    ChIP-seq experiments were performed in duplicate.

    “The reads from duplicate experiments were combined and mapped to the C. glabrata CBS138 genome using HISAT2 [43].”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductnone given

    All constructs were verified by Sanger sequencing.

    “All constructs were verified by Sanger sequencing (University of Iowa Genomic Core)”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation

    Extensive previous work on Upc2A homologues in both S. cerevisiae and C. albicans was generally done prior to the availability of modern genomic approaches like ChIP- and RNA-seq.

    “Extensive previous work on Upc2A homologues in both S. cerevisiae and C. albicans was generally done prior to the availability of modern genomic approaches like ChIP- and RNA-seq (reviewed in [36]).”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [36] PJ Espenshade, 2007, Regulation of sterol synthesis in eukaryotes, Annu Rev Genet source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

    Premisecitation

    UPC2 mutations in C. albicans have been found in multiple clinical strains and appear to be much more commonly isolated.

    “UPC2 mutations in C. albicans have been found in multiple clinical strains and appear to be much more commonly isolated [23,24].”
    Quote in the paperNot a substantial claim0 of 2 sources checked
    • cites [23] CJ Heilmann, 2010, An A643T mutation in the transcription factor Upc2p causes constitutive ERG11 upregulation and increased fluconazole resistance in Candida albicans, Antimicrob Agents Chemother source

      Not checked in the free run.

    • cites [24] SJ Hoot, 2011, An A643V amino acid substitution in Upc2p contributes to azole resistance in well-characterized clinical isolates of Candida albicans, Antimicrob Agents Chemother source

      Not checked in the free run.

  • May combine two claims.

    Interpretationreasoning

    ERG genes are an important set of genetic targets for Upc2A but are a small fraction of the whole.

    “Clearly, the ERG genes are an important set of genetic targets but these are a small fraction of the whole.”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation

    Detailed analyses demonstrated the crucial role of Upc2A-like factors in regulation of ERG gene biosynthesis.

    “Detailed analyses demonstrated the crucial role of these Upc2A-like factors in regulation of ERG gene biosynthesis [30,37,38] but little was known about the full range of their target genes.”
    Quote in the paperNot a substantial claim0 of 3 sources checked
    • cites [30] A Vik, 2001, Upc2p and Ecm22p, dual regulators of sterol biosynthesis in Saccharomyces cerevisiae, Mol Cell Biol source

      Not checked in the free run.

    • cites [37] PM Silver, 2004, Role of Candida albicans transcription factor Upc2p in drug resistance and sterol metabolism, Eukaryot Cell source

      Not checked in the free run.

    • cites [38] S MacPherson, 2005, Candida albicans zinc cluster protein Upc2p confers resistance to antifungal drugs and is an activator of ergosterol biosynthetic genes, Antimicrob Agents Chemother source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductnone given

    Western immunoblot target band fluorescence intensity was normalized against tubulin fluorescence intensity and compiled from 2 biological replicate experiments and 2 technical replicates in each experiment, giving 4 replicates in total.

    “Detected target band fluorescence intensity was normalized against tubulin fluorescence intensity and compiled from 2 biological replicate experiments and 2 technical replicates in each experiment, giving 4 replicates in total.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Interpretationnone given

    The limited spectrum of genes induced by G898D Upc2A may reflect more complex requirements at these promoters for their activation beyond Upc2A occupancy.

    “The limited spectrum of genes that is induced by G898D Upc2A may reflect more complex requirements at these promoters for their activation beyond Upc2A occupancy.”
    Quote in the paperNot a substantial claim
60 of 60
  • The paper relies on this without support.

    Genes bound by Upc2A in ChIP-seq and responsive to Upc2A are direct transcriptional targets of Upc2A.

    “The simplest class of fluconazole-induced genes are represented by the 53 direct target genes. These genes are both bound by Upc2A and respond to regulation via this factor.”
  • The paper relies on this without support.

    C. glabrata has a high level of intrinsic azole resistance.

    “could help explain the high level of intrinsic azole resistance seen in this organism.”
  • The paper relies on this without support.

    There has been no follow-up linking C. albicans Upc2 with the Tac1 transcription factor or S. cerevisiae Upc2 with either ScPDR1 or ScPDR3.

    “To the best of our knowledge, there has been no follow-up linking C. albicans Upc2 with the Tac1 transcription factor (key regulator of CDR1 transcription) or S. cerevisiae Upc2 with either ScPDR1 or ScPDR3.”
  • The paper relies on this without support.

    No other S. cerevisiae UPC2 hypermorphic alleles are known.

    “Strikingly, no other S. cerevisiae UPC2 hypermorphic alleles are known.”
  • The paper relies on this without support.

    Ergosterol production and its synchronization with biogenesis of membrane proteins in the plasma membrane is central to a fungal cell producing a normally functioning membrane that can allow growth.

    “The importance of ergosterol production and its synchronization with biogenesis of membrane proteins in the plasma membrane is central to a fungal cell producing a normally functioning membrane that can allow growth.”
  • The paper relies on this without support.

    Fluconazole treatment causes ergosterol limitation in C. glabrata.

    “we propose that C. glabrata Upc2A accumulates in the nucleus upon ergosterol limitation.”
6 of 6

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • C. glabrata Upc2A controls expression of genes beyond those involved in ergosterol biosynthesis, including genes associated with translation and plasma membrane constituents.

    “Intriguingly, recent work demonstrated an expansive role of C. glabrata Upc2A (C. glabrata homologue of C. albicans Upc2) in controlling the expression of genes beyond those involved in ergosterol biosynthesis, including those associated with translation and plasma membrane constituents27.”

    From Molecular mechanisms governing antifungal drug resistance (2023) · cites this paper as [27]

  • Upc2A also regulates CDR1 expression and extensive overlap exists between the regulatory networks mediated by Upc2A and Pdr1 in C. glabrata.

    “Recently, it was demonstrated that the zinc cluster transcription factor Upc2A also regulates CDR1 expression and that extensive overlap exists between the regulatory networks mediated by Upc2A and Pdr1 in C. glabrata27,59.”

    From Molecular mechanisms governing antifungal drug resistance (2023) · cites this paper as [27]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

  • ERG8 is described as both Upc2A-dependent and Upc2A-independent

    Major

    ERG8 is listed among genes that require Upc2A for fluconazole induction, but a later passage says it is similarly induced with and without Upc2A.

  • Gain-of-function allele is called G899D once

    Minor

    The allele characterized throughout the paper is G898D UPC2A, but this passage calls it G899D UPC2A.

2 of 2

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Vu, B. G., Stamnes, M. A., Li, Y., Rogers, P. D., & Moye-Rowley, W. S.
Affiliations
  • University of Iowa (US)
  • University of Tennessee Health Science Center (US)
Venue
PLOS Genetics
Published
2021-09-30
Volume
17
Issue
9
Pages
e1009582
ISSN
  • 1553-7390 (ISSN-L)
  • 1553-7404
OpenAlex
W3202652055
Cited by
39
References
50
Citations by year
2026: 7 · 2025: 8 · 2024: 12 · 2023: 4 · 2022: 7 · 2021: 1
FWCI
1.90
Type
journal article
Language
en
Open access
Locations
  • PLoS Genetics (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
National Institute of Allergy and Infectious Diseases (R01AI152494, R01AI131620)
Topics
  • Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fungal and yeast genetics research
  • Life Sciences › Agricultural and Biological Sciences › Ecology, Evolution, Behavior and Systematics › Fungal Plant Pathogen Control
Keywords
Candida glabrata, antifungal resistance, azole resistance, fluconazole, PDR1, CDR1, ergosterol biosynthesis, transcriptional regulatory networks, membrane protein biosynthesis, lipogenesis, caspofungin resistance, transcription factor binding sites
MeSH terms
Gain of Function Mutation, Antifungal Agents, Genes, Fungal, Mutation, Transcription Factors, Transcription, Genetic, Fluconazole, Gene Expression Regulation, Fungal, Drug Resistance, Fungal, Candida glabrata, Chromatin Immunoprecipitation, Gene Regulatory Networks, Transcriptome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-09.

Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-09.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review